# 18F-FET-PET/MRI vs Standard MRI Alone for Stereotactic RadioTherapy Planning for High Grade Brain Gliomas

> **NCT06499831** · NA · ACTIVE_NOT_RECRUITING · sponsor: **Sunnybrook Health Sciences Centre** · enrollment: 30 (estimated)

## Conditions studied

- Glioma, Malignant

## Interventions

- **DIAGNOSTIC_TEST:** 0-(2-18F-Fluoroethyl)-L-Tyrosine

## Key facts

- **NCT ID:** NCT06499831
- **Lead sponsor:** Sunnybrook Health Sciences Centre
- **Sponsor class:** OTHER
- **Phase:** NA
- **Study type:** INTERVENTIONAL
- **Status:** ACTIVE_NOT_RECRUITING
- **Start date:** 2021-12-15
- **Primary completion:** 2025-01-31
- **Final completion:** 2026-01-31
- **Target enrollment:** 30 (ESTIMATED)
- **Last updated:** 2025-05-25


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT06499831

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT06499831, "18F-FET-PET/MRI vs Standard MRI Alone for Stereotactic RadioTherapy Planning for High Grade Brain Gliomas". Retrieved via AI Analytics 2026-06-02 from https://api.ai-analytics.org/clinical/NCT06499831. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*